Key result
Integrated anatomical and functional imaging guides risk stratification and appropriate coronary revascularization in CCS patients.
Why the study?
Recent trials questioning the efficacy of revascularization versus optimal medical therapy in chronic coronary syndromes, alongside real-life underuse of prior non-invasive imaging and pandemic-related changes, have sparked debate over the role of imaging.
Does non-invasive cardiac imaging improve risk stratification and outcomes when guiding coronary revascularization in patients with stable coronary artery disease?
Does non-invasive cardiac imaging improve risk stratification and outcomes when guiding coronary revascularization in patients with stable coronary artery disease?
This review emphasizes the critical role of integrating anatomical and functional non-invasive imaging to appropriately select patients with chronic coronary syndromes for invasive angiography and revascularization.
Answers are grounded in this paper and cite their sources.
May support integrated imaging for CCS revascularization decisions; leaves open need for randomized outcome trials.
In the last decades, the effective management of some cardiovascular risk factors in the general population has led to a progressive decrease in the prevalence of coronary artery disease (CAD). Nevertheless, coronary heart disease remains the major cause of death in developed and developing countries and chronic coronary syndromes (CCS) are still a major target of utilization of non-invasive cardiac imaging and invasive procedures. Current guidelines recommend the use of non-invasive imaging in patients with CCS to identify subjects at higher risk to be referred for invasive coronary angiography and possible revascularization. These recommendations are challenged by two opposite lines of evidence. Recent trials have somewhat questioned the efficacy of coronary revascularization as compared with optimal medical therapy in CCS. As a consequence the role of imaging in these patients and in in patients with ischemic cardiomyopathy is under debate. On the other hand, real-life data indicate that a consistent proportion of patients undergo invasive procedure and are revascularized without any previous non-invasive imaging characterization. On top of this, the impact of COVID-19 pandemic on the sanitary systems caused a change in the current management of patients with CAD. In the present review we will discuss these conflicting data analyzing the evidence which has been recently accumulated as well as the gaps of knowledge which should still be filled.
No takes yet. Share an insight, caveat, or question.
Neglia et al. (2021) conducted a review in Stable Coronary Artery Disease. Cardiac imaging-guided coronary revascularization vs. Standard care / Optimal medical therapy was evaluated. An integrated anatomical and functional imaging strategy is recommended to risk-stratify patients with chronic coronary syndromes and guide appropriate coronary revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: